« Back to Record
Majewski, I. I., Nuciforo, P., Mittempergher, L., Bosma, A. A., Eidtmann, H., Holmes, E., Sotiriou, C., Fumagalli, D., Jimenez, J., Aura, C. M., Prudkin, L., Díaz-Delgado, M. C., de la Peña, L., Loi, S., Ellis, C., Schultz, N., de Azambuja, E., Harbeck, N., Piccart-Gebhart, M., Bernards, R., & Baselga, J. (2015). PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer. Journal of clinical oncology. doi:10.1200/JCO.2014.55.2158
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/186678



